Tag Archives: Takes

Novartis’ Kisqali takes step back in heated market after NICE no vote

With sales of its breast cancer drug Kisqali lagging, Novartis saw an opening in the U.K. market to gain ground on its competitors. Now that door has swung shut. In draft guidance published Wednesday, the National Institute for Health and Care Excellence (NICE) chose not to recommend Kisqali (ribociclib) for treatment of women with hormone… Read More »

As flu season takes a turn for the worse, some schools close in at least 12 states

There have been as many as 11.4 million flu illnesses, 5.4 million medical visits and 136,000 flu hospitalizations between October 1, 2018 and January 19, 2019, according to the weekly flu report released Friday by the US Centers for Disease Control and Prevention. During the week that ended January 19, the CDC reported three additional… Read More »